adalimumab,abatacept
bms,abbvie
[' ada ', 'ada ', 'ample study']
early ample study proteomic analysis showed 3 potential biomarkers (angpt1, tnfrsf10c, and gif) for predicting cv risk/ra tx response to aba vs ada in abs 0244. possible new markers for personalized medicine? can't wait to see more! #acr22 
Passionately curious rheumatologist, world traveler, wife, mother, sister, daughter, friend, dog lover. Believer in scientific method & evidence based medicine.